title: Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcu aureus surveillance: a 60-month study.
abstract: It is not known whether or not ward-specific antimicrobial use density (AUD) affects the ratio of methicillin-resistant Staphylococcus aureus (MRSA) in culture-positive S. aureus. A 60-month study was attempted to ascertain the association between inpatient MRSA ratio and ward-specific AUDs as well as the former and latter study intervals, specimen types, and ward specialty. During the study, the professionals in infection control regulated the use of broad-spectrum antimicrobials and those for MRSA. By both month and ward, the ratio of inpatients positive for MRSA to those positive for S. aureus was calculated. Factors associated with MRSA ratio included AUDs averaged for the sampling month and its previous month, outpatient MRSA ratio by age, ward specialty, specimen type, and half intervals to represent historical changes. Of a total of 4,245 strains of S. aureus isolated during the 5-year study, 2,232 strains (52.6%) were MRSA. By year, outpatient MRSA ratio at age ≥15 decreased in later years, as did inpatient MRSA ratio. Multivariate analysis for inpatient MRSA ratio revealed a positive risk in AUDs for meropenem (odds ratio [OR] 1.761; 95% confidence interval [CI] 1.761-2.637, P = 0.01), imipenem-cilastatin (OR 1.583; 95% CI 1.087-2.306, P = 0.02), ampicillin-sulbactam (OR 1.623; 95% CI 1.114-2.365, P = 0.01), and minocycline (OR 1.680; CI 1.135-2.487, P = 0.01), respiratory care ward (OR 2.292; 95% CI 1.085-4.841, P = 0.03), and outpatient MRSA ratio (OR 1.536; 95% CI 1.070-2.206, P = 0.02). Use of broad-spectrum antimicrobials, such as meropenem, imipenem-cilastatin, and ampicillin-sulbactam may increase inpatient MRSA ratio. Ward factor should be included in MRSA surveillance because of the possible effect on AUD and considering patients' backgrounds.
authors.affiliation: Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Yamaguchi, Japan.
authors.forename: Junichi
authors.initials: J
authors.lastname: Yoshida
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kikuchi
authors.forename: Nobuo
authors.initials: N
authors.lastname: Matsubara
authors.forename: Ikuko
authors.initials: I
authors.lastname: Asano
authors.forename: Nobumichi
authors.initials: N
authors.lastname: Ogami
keywords: methicillin-resistant Staphylococcus aureus; respiratory tract; surveillance
references.citation: Infect Control Hosp Epidemiol. 2008 Jun;29(6):496-502
references.pmid: 18510458
references.citation: Am J Infect Control. 2006 Apr;34(3):108-13
references.pmid: 16630972
references.citation: Clin Infect Dis. 2003 Jul 15;37(2):180-6
references.pmid: 12856209
references.citation: J Antimicrob Chemother. 2008 Sep;62(3):601-7
references.pmid: 18468995
references.citation: J Infect Chemother. 2012 Apr;18(2):269-71
references.pmid: 21894454
references.citation: J Infect. 2007 Oct;55(4):358-62
references.pmid: 17692383
references.citation: Antimicrob Agents Chemother. 2007 May;51(5):1656-60
references.pmid: 17353249
references.citation: Antimicrob Agents Chemother. 2011 Oct;55(10):4888-95
references.pmid: 21788461
references.citation: J Infect Chemother. 2008 Feb;14(1):15-22
references.pmid: 18297444
references.citation: Jpn J Infect Dis. 2011;64(5):436-8
references.pmid: 21937829
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):657-68
references.pmid: 16447111
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Dec;28(12):1447-56
references.pmid: 19727869
references.citation: J Clin Microbiol. 2005 Dec;43(12):6161-3
references.pmid: 16333120
references.citation: Infect Control Hosp Epidemiol. 1998 Jun;19(6):388-94
references.pmid: 9669619